Detected ·
Tectora Therapeutics
$55M—
Tectora Therapeutics launched with a $55M Series A to develop innovative therapies for immunology and inflammation, co-founded by NEA, RA Capital Management, and Schrödinger.
- Website
- —
- —
- Amount
- $55 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-11 04:02:26 UTC
- Signal ID
- 9084be02-d795-4e66-8ca8-3bcc36a107a0
As the API returns it
{
"id": "9084be02-d795-4e66-8ca8-3bcc36a107a0",
"created_at": "2026-09-11T04:02:26.033093Z",
"company_name": "Tectora Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 55000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Tectora Therapeutics launched with a $55M Series A to develop innovative therapies for immunology and inflammation, co-founded by NEA, RA Capital Management, and Schrödinger.*"
}